You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國生物科技服務(08037.HK)成為華大基因分銷商以向海外銷售新型冠狀病毒試劑盒
格隆匯 03-16 17:44

格隆匯3月16日丨中國生物科技服務(08037.HK)公佈,於2020年3月16日,公司一間間接非全資附屬公司亞洲分子診斷實驗室有限公司已與深圳華大基因股份有限公司附屬公司華大基因健康科技(香港)有限公司訂立分銷協議。

華大基因健康香港已經同意委任亞洲分子診斷為華大基因健康香港的用於檢測2019-nCoV的實時熒光RT-PCR試劑盒在歐洲聯盟、美利堅合眾國、亞洲(南韓、日本、泰國、文萊、以色列、阿拉伯聯合酋長國除外)、澳洲及加拿大的戰略分銷商。該試劑盒是中國國家藥品監督管理局批准上市的用於檢測新型冠狀病毒的產品,並已經獲得丹麥醫藥管理局(Danish Medicines Agency)頒發的關於歐盟體外診斷醫療器械的自由銷售證書(Free Sales Certificate),並計劃上述國家和地區與當地合作的實驗室共同推出新冠病毒檢測服務。分銷協議有效期為三年。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account